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Alterations in RNA splicing and cancer
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Data from The Cancer Genome Research Atlas








Alterations in lung adenocarcinoma
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The oncological unmet need: lung cancer
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Increased levels of 
NUMB exon 9 
inclusion
The oncological unmet need: lung cancer
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NUMB skipped exon (chr14: 73749067-73744001, negative
strand, hg19)
PSI cutoff: 0.65; Log-rank p-value: 2.46e-05
Inclusion levels >= 0.65 Inclusion levels < 0.65


















Patients with NUMB PSI > 0.65
Patients with NUMB PSI < 0.65
n=95
n=408
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Three key regulatory regions were identified
NUMB exon 9
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Orthotopic A549 all AON
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Implantation of A549 cells
Mesurement
Tumor detection
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• Lung cancer is an unmet medical need.
• NUMB alternative splicing represents a novel target, altered in all LUAD samples.
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